This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Harold E. Resinger, MD
Lexington, Ky

JAMA. 1983;250(19):2602.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

It is being widely stated that the new Tax Equity and Fiscal Responsibility Act/Diagnosis Related Groups laws and regulations will change the practice of clinical pathology greatly and may decimate it. The idea that it will change is valid, but the idea that will be decimated is not.

Out of these governmental adversities have come outstanding opportunities. Under the new laws and regulations, hospital administration will direct its primary efforts toward rapid diagnosis and treatment and early discharge of patients to reduce the cost of hospitalization. The clinical pathologist sits in the best position ever to lead the medical staff and administration in best achieving such. The knowledgeable choice of laboratory tests and efficient management of laboratory operations can maximize the flow-through of patients in achieving appropriate diagnoses and treatment. Either before or immediately on admission, the patient should receive a broad profiling of laboratory tests appropriate . . . [Full Text PDF of this Article]

Footnotes
Edited by John D. Archer, MD, Senior Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?